Adicet Bio (NASDAQ:ACET – Get Free Report) had its price objective lowered by research analysts at HC Wainwright from $26.00 to $10.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 228.95% from […]
Adicet Bio (NASDAQ:ACET – Get Free Report) had its price objective reduced by analysts at HC Wainwright from $26.00 to $10.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 228.95% from the stock’s current […]
Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) Director Orbimed Advisors Llc bought 3,125,000 shares of the company’s stock in a transaction on Thursday, January 25th. The stock was purchased at an average cost of $2.40 per share, with a total value of $7,500,000.00. Following the completion of the transaction, the director now owns 7,526,359 […]
Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) Director Orbimed Advisors Llc purchased 3,125,000 shares of the business’s stock in a transaction that occurred on Thursday, January 25th. The shares were bought at an average price of $2.40 per share, for a total transaction of $7,500,000.00. Following the completion of the purchase, the director now […]
Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) Director Orbimed Advisors Llc purchased 3,125,000 shares of the business’s stock in a transaction that occurred on Thursday, January 25th. The shares were bought at an average price of $2.40 per share, for a total transaction of $7,500,000.00. Following the completion of the purchase, the director now […]